The US Food and Drug Administration (FDA) has approved an oral solution of calcium, magnesium, potassium, and sodium oxybates (Xywav, Jazz Pharmaceuticals) for treatment of cataplexy or excessive ...

A prospective study concluded that patients with narcolepsy can safely switch from a high-sodium oxybate to a low-sodium oxybate to manage their symptoms. In January of 2017, the FDA approved oral SXB ...

In older adults, low sodium often results from certain medications, kidney issues, or infections. Because multiple factors may contribute, treatment depends on identifying the underlying cause. Sodium ...

First presentation of the Phase 4 XYLO switch study reports blood pressure reductions in patients with narcolepsy when switching from twice-nightly high- to low-sodium oxybate Novel intermediate ...

In older age, low sodium tends to be caused by taking certain medications, kidney problems, or infection. However, there can be multiple causes, and the treatment depends on the cause. Sodium is an ...

Switching from a higher to a lower-sodium dose of Xywav led to significant reductions in 24-hour blood pressure for ...

DUBLIN, Sept. 22, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced new real-world evidence and Phase 4 data reinforcing the value of Xywav ® (calcium, magnesium, potassium, ...

DUBLIN, Oct. 31, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that eight abstracts presenting data from across its sleep portfolio were featured at the 37th annual ...

Dear Dr. Roach: My mother’s blood test has a sodium level of 130 mEq/L. She is not on diuretics, and she does not have heart or kidney problems. She is on thyroid medication and omeprazole. Do I need ...

Free home-delivered groceries tailored to the low-sodium Dietary Approaches to Stop Hypertension diet improved blood pressure ...